B. Riley Wealth Advisors’s Cocrystal Pharma COCP Stock Holding History

B. Riley Wealth Advisors’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,061	Closed	-$4K	–	1508
2022 Q3	$4K	Hold	1,061	–	–	﹤0.01%	1444
2022 Q2	$6K	Hold	1,061	–	–	﹤0.01%	1224
2022 Q1	$7K	Hold	1,061	–	–	﹤0.01%	1377
2021 Q4	$9K	Hold	1,061	–	–	﹤0.01%	1405
2021 Q3	$14K	Hold	1,061	–	–	﹤0.01%	1400
2021 Q2	$16K	Hold	1,061	–	–	﹤0.01%	1366
2021 Q1	$18K	Hold	1,061	–	–	﹤0.01%	1340
2020 Q4	$18K	Hold	1,061	–	–	﹤0.01%	1023
2020 Q3	$12K	Hold	1,061	–	–	﹤0.01%	938
2020 Q2	$20K	Hold	1,061	–	–	﹤0.01%	857
2020 Q1	$10K	Hold	1,061	–	–	﹤0.01%	783
2019 Q4	$7K	Hold	1,061	–	–	﹤0.01%	834
2019 Q3	$27K	Hold	1,061	–	–	﹤0.01%	798
2019 Q2	$30K	Hold	1,061	–	–	﹤0.01%	782
2019 Q1	$35K	Hold	1,061	–	–	﹤0.01%	732
2018 Q4	$46K	Hold	1,061	–	–	0.01%	646
2018 Q3	$32K	Hold	1,061	–	–	﹤0.01%	709
2018 Q2	$47K	Hold	1,061	–	–	0.01%	665
2018 Q1	$76K	Buy	+1,061	New	+$66.2K	0.01%	639

Other funds holding COCP

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

B. Riley Wealth Advisors's COCP Position: Q4 2022 in Review

B. Riley Wealth Advisors sold out of Cocrystal Pharma (COCP) in Q4 2022, closing a stake of 1,061 shares — an estimated $4K sold.

B. Riley Wealth Advisors first reported a position in COCP in Q1 2018 and held it in 19 quarters. The position peaked at $76K in Q1 2018. 21 funds tracked by Wall St. Rank hold COCP as of Q4 2022.

B. Riley Wealth Advisors reported no remaining Cocrystal Pharma position as of Q4 2022 after selling out during the quarter.
B. Riley Wealth Advisors sold 1,061 Cocrystal Pharma shares in Q4 2022, an estimated $4K.
B. Riley Wealth Advisors first reported a position in Cocrystal Pharma in Q1 2018 and held it in 19 quarters.
B. Riley Wealth Advisors's Cocrystal Pharma position peaked at $76K in Q1 2018.
21 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q4 2022.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2022, filed 21 Feb 2023.